Ledger.Open graph →

SEC Form D · filed April 22, 2021

Evozyne, Inc

Offering

$59.2M

Sold

$54.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CHICAGO, IL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Rama J. Ranganathan · Chicago, ILExec · Director Antonio S. Gracias · Chicago, ILDirector Darien S. Parhad · Chicago, ILExec Patrick J. Morris · Chicago, ILExec · Director Jeffrey S. Aronin · Chicago, ILDirector Aris J. Theologis · Chicago, ILExec · Director Meg B. Stallard · SAN FRANCISCO, CAExec · Director Catherine Covington · SAN FRANCISCO, CAExec · Director Karl Scott · New York, NYDirector Leah Bradford Francis · SAN FRANCISCO, CAExec Rushton G. Mcgarr · Boulder, CODirector Justin B. Morales · SAN FRANCISCO, CAExec · Director Brad Lubrand · Chicago, ILExec · Director Jon R. Mcgurk · Fairlawn, OHExec · Director Jaime U. Kolligian · Fairlawn, OHExec Colin Butterfield · Boston, MAExec · Director Thomas Mclaughlin · San Juan, Puerto RicoDirector Amelia K. Siamomua · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗